Exoskeleton (Industrial and Rehabilitative)

EksoNR 400x275Ekso Bionics Holdings, which develops exoskeleton technology for medical and industrial usages, has announced expanding its partnership with Kindred Healthcare. The expansion will bring EksoNR, its robotic exoskeleton, to four of Kindred’s long-term acute care (LTAC) hospitals in the U.S. The multi-unit order follows a successful pilot program of the EksoNR last year, the company said.

 

GermanBionic400x275German Bionic, which manufactures smart power suits for industrial applications, has announced that functional updates can be performed via wireless remote transmission. The German Bionic OS, which connects the power suits to the cloud, makes this possible, the Augsburg, Germany-based company said in a statement.

 

HarmonicBionics400x275Harmonic Bionics, a robotics company that aims to augment human movement, has announced closing $7 million in Series A funding. The new funds will support the company’s clinical research efforts and enable an increase in product development to bringing its advanced upper extremity rehabilitation technology to market.

 

Sarcos merger400x275Sarcos Robotics, which develops robots and exoskeleton systems that augment humans for productivity and safety, has announced it will become publicly listed through a merger transaction with Rotor Acquisition Corp., a publicly traded special purpose acquisition company (SPAC). The transaction is expected to provide the company with up to $496 million of proceeds before expenses to fund business plans, facilitate potential bolt-on acquisitions, and enhance capabilities.

Exoskeleton400x275Driven by high injury costs and an aging and shrinking skilled workforce across sectors, the global industrial exoskeletons market is expanding rapidly, a new analysis by Frost & Sullivan says. The company is estimating a nearly seven-fold growth for the market, with an expected value of $426.6 million by 2025, and an annual compound annual growth rate of 46.7%

CeleraMotionCapitan400x275Celera Motion, which develops precision motion component and sub-system solutions, has announced its Capitan Series to their line of premium performance Ingenia servo drives. The drives are aimed to deliver maximum performance for applications that include surgical robotics, exoskeletons, robotic joints and end effectors, among others.

 

OrthoSpinGen2 400x275OrthoSpin Ltd. announced it has received regulatory clearance from the U.S. Food and Drug Administration (FDA) for its second generation, robotic, digitally-enabled external fixation system for orthopedic treatments. The OrthoSpin G2 system is also approved in Israel, and can be used with the DePuy Synthes MAXFRAME Multi-Axial Correction System, the company said.

 

GermanBionic 400x275Robotic exoskeleton maker German Bionic announced it closed $20 million in Series A financing. The round was led by Samsung Catalyst Fund and MIG AG, with participation from Storm Ventures, Benhamou Global Ventures, and IT Farm.